Heart valve disease, a new comorbidity identified in TNF dependent arthritis models
Biomedcode scientists coauthor two publications, one in Annals of Rheumatic diseases and one in JCI insight, showing that Tg197 and TNFΔΑRΕ mice...
20 MAR 2018
Therapeutic Areas - Animal models
News
Pharma News
FAQ - Top 10 Questions
Q2: What are Biomedcode's services at a glance?
Biomedcode is modeling human inflammatory conditions:
Client Testimonials - What our clients say about us
Our company had a pleasant experience of productive collaboration with Biomedcode s.a. in 2015. We would like to especially highlight...Quote from Biopharmaceutical company, Moscow, Russia
Events and Webinars
Our Activity
Biomedcode was founded in 2006, as a spin-off of the Biomedical Sciences Research Center “Alexander Fleming”
Biomedcode has extensive expertise & scientific excellence in inflammatory & autoimmune animal disease models
Our mouse models of arthritis were instrumental in proving the efficacy of anti-hTNF therapeutics in arthritis
Biomedcode’s clients include top 5 worldwide pharmaceutical companies
Publications
Mesenchymal TNFR2 promotes the development of polyarthritis and comorbid heart valve stenosis
Biomedcode scientists coauthor a publication in JCI insight showing that TNFΔARE mice develop mesenchymal cell dependent heart valve pathology with...
Comorbid TNF-mediated heart valve disease and chronic polyarthritis share common mesenchymal cell-mediated...
Biomedcode scientists coauthor a publication in Annals of Rheumatic diseases showing that Tg197 mice develop heart valve pathology sharing common...
Targeted metabolic profiling of the Tg197 mouse model reveals itaconic acid as a marker of Rheumatoid Arthritis.
Biomedcode coauthors a publication on the identification of a biomarker with translational value for the diagnosis & monitoring of rheumatoid...Members Login
If you would like to become member please send us an email at:
or simply fill out our online proposal form
Online Prosposal Form